McKesson Corp. (NYSE:MCK) had its target price boosted by Lazard Capital Markets from $130.00 to $136.00 in a report issued on Wednesday, AnalystRatingsNetwork.com reports. They currently have a buy rating on the stock.
McKesson Corp. (NYSE: MCK) traded up 0.03% on Wednesday, hitting $118.52. McKesson Corp. has a 52-week low of $84.65 and a 52-week high of $119.56. The stock’s 50-day moving average is currently $114.. The company has a market cap of $26.858 billion and a price-to-earnings ratio of 21.19.
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a neutral rating on shares of McKesson Corp. in a research note to investors on Wednesday. They now have a $124.00 price target on the stock. Separately, analysts at TheStreet reiterated a buy rating on shares of McKesson Corp. in a research note to investors on Wednesday, July 10th. Finally, analysts at JPMorgan Chase & Co. reiterated an overweight rating on shares of McKesson Corp. in a research note to investors on Thursday, June 27th.
Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of $122.45.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.